Follow last change Dec 2010 re-read 3 minutes ago

HIG2

Developed for: renal cell carcinoma
Investigated by: Human Genome Center, Institute of Medical Science, University of Tokyo · Iwate Medical University

today NCT01254838 · Ph 1

2009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT01254838	Nov 2008 → Dec 2010	renal cell carcinoma	Iwate Medical University	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	HIG2	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01254838 ↗